Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue

OTTAWA, ON, July 29, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc("Tetra" or the Company")(TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that itfiled a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.